Technology
Health
Biotechnology

X4 Pharmaceuticals

$13.09
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.88 (7.21%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell XFOR and other stocks, options, ETFs, and crypto commission-free!

About XFOR

X4 Pharmaceuticals, Inc. operates as a biotechnology company, which engages in developing human antibodies for treating infectious diseases. The company focuses on restoring healthy immune system function by developing novel therapeutics for the treatment of rare diseases. Read More Its products in pipeline include X4P-001, X4P-002, and X4P-003. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan and is headquartered in Cambridge, MA.

Employees
15
Headquarters
Cambridge, Massachusetts
Founded
Market Cap
162.71M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
12.67K
High Today
$13.58
Low Today
$12.34
Open Price
$12.34
Volume
19.75K
52 Week High
$29.46
52 Week Low
$6.90

Collections

Technology
Health
Biotechnology
Therapy
2017 IPO
US
North America
Female CEOs
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.